Getinge buds of its business area Patient & Post-Acute Care, which previously went under the name of Extended Care, was a positive bang and the stock market seems, given the rise in the course appreciate the action. The mean hälsovårdsanalytiker as the News agency Directly been in contact with after the report.
“the Drama is of course that the buds Patient & Post-Acute Care”, concludes Johan Unnnerus, at the Swedbank Markets, which explains the rise in prices with the spin-off of the business area.
Around at 14.20 had Getinge has risen by more than 4 percent on Tuesday.
Johan Unnnerus continues:
“It’s a great news considering that storägaren Carl Bennett wanted to move in the structure in the past. It opens up for a faster change in the group and you can probably get up profitability in the future. It creates a greater freedom which allows you to take the social tag”.
Peter Östling, an analyst at Pareto Securities, I also think that it is surprising that the business area is spun off, and he describes it as the icing on the cake after a report was better than expected.
“My first interpretation is that the market had expected a much worse report than what it was. The report is roughly in line with consensus. But I think the silent expectation was that it would be even worse,” says Pareto analyst.
Peter Östling also welcome the spin-off of Extended Care, which he says does not really fit in with the rest of the Getinge business.
Patient & Post-Acute Care, in the past, therefore, Extended Care, dealing with solutions for lifting and moving of patients, while the other two business areas, Surgical Workflows and Acute Care Therapies, sells products that are directly hospital-acquired.
Surgical Workflows to develop solutions for infection control and operating theatres, while Acute Care Therapies concerned with solutions for life-sustaining care.
“How you twist and turn the cube so the ports Exended Care outside the where there are no clear synergies with the other operations”.
He continues, regarding the spin-off:
“It is the grip you take. Getinge has always been buyers of businesses. I am surprised that it actually happened, but strategically, it is absolutely right”.
the company reserves the sek 400 million in connection with the programme of action in the German Hechingen-factory post Peter Östling also pluskontot and indicates that the market now has something to relate to.
DNB Markets is pointing in a snabbkommentar to Getinge’s profit before non-recurring items, after all, ended up in line with the consensus, and it deserves a positive kursreaktion.
the ABG is also surprised by the spin-off, pointing out that the company now actually reserved an amount of Hechingen-plant as well as the Getinge not related to their long-term goals as explanatory factors behind the rise in prices. However, the form does not report any “game-changer”, according to the ABG’s snabbkommentar.
At 14.10 o’clock on Tuesday had medicinteknikaktien has risen nearly 5 percent to around 164 sek. So far this year is the decline, however, the entire 26 per cent.
No comments:
Post a Comment